Skip to main content
    S

    SBC Medical Group Holdings Incorporated (SBC)

    Official site

    INDUSTRIALS • CONSULTING SERVICES • NASDAQ

    $6.12
    -0.06 (-0.97%)

    Market Cap: $633.93M

    Last updated: Nov 17, 2026 at 4:26 PM ET

    SBC Medical Group Holdings Incorporated (SBC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    SBC Medical Group Holdings (SBC) has a market cap of $633.93M and an enterprise value of $469.10M. Its return on invested capital of 16.95% compares with a 0.50% median across 7 similar companies. It holds $164.83M more cash than debt, 26.00% of its market cap.

    Total Valuation

    Enterprise value is 26.00% below the market cap, as cash exceeds debt.

    Market Cap$633.93M
    Enterprise Value$469.10M
    Latest price (Nov 17, 2026)$6.12

    Key Dates

    The next earnings report is expected on Mar 25, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 25, 2027 (expected)
    Last Earnings DateNov 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and grew 3.86% a year over 2 years.

    Shares Outstanding102.58M
    Shares Change (YoY)-0.06%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)+3.86%

    Valuation Ratios

    Sales and book value multiples are 3.3x and 2.2x.

    P/E Ratio12.2x
    Forward P/E13.5x
    P/S Ratio3.3x
    Forward P/S3.0x
    P/B Ratio2.2x
    P/TBV Ratio2.8x
    P/FCF Ratio6.3x
    P/OCF Ratio6.2x
    PEG Ratio2.5

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 5.3x EBITDA and 4.6x free cash flow.

    EV / Earnings8.8x
    EV / Sales2.5x
    EV / EBITDA5.3x
    EV / FCF4.6x

    Price Statistics

    The stock is up 84.89% over 52 weeks and trades 17.69% above its 50-day average.

    Beta (1Y)0.91
    52-Week Change+84.89%
    1-Month Change+14.18%
    3-Month Change+58.14%
    6-Month Change+111.76%
    Total Return (1Y)+84.89%
    Return vs SPY (1Y)+81.50%
    Max Drawdown (1Y)-41.67%
    Max Drawdown (3Y)-70.14%
    Sharpe Ratio (1Y)1.01
    Correlation with SPY (1Y)0.19
    50-Day Average$5.20
    200-Day Average$3.98
    52-Week Range$2.78 to $7.39
    RSI (14 Days)57.9
    Average Volume (20 Days)343.77K

    Price chart

    Financial Position

    Current assets cover 3.67x current liabilities, and total debt is 0.12x shareholder equity.

    Current Ratio3.67x
    Quick Ratio3.63x
    Debt / Equity0.12x
    Debt / EBITDA0.39x
    Debt / FCF0.34x
    Interest Coverage194.48x

    Returns and Efficiency

    Return on invested capital is 16.95% and return on equity is 18.54% over the last 12 months.

    Return on Equity (ROE)18.54%
    Return on Assets (ROA)12.52%
    Return on Invested Capital (ROIC)16.95%
    Asset Turnover0.51x
    Inventory Turnover17.87x
    Receivables Turnover2.57x
    Cash Conversion Cycle-9 days

    Taxes

    Income tax took 34.81% of pretax income over the last 12 months.

    Income Tax (TTM)$29.02M
    Effective Tax Rate34.81%

    Scores

    SBC has an Altman Z-Score of 5.68, in the safe zone above 2.99, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score5.68
    Altman Z ZoneSafe
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $190.40M over the last 12 months is up 6.69% from the 12 months before.

    Revenue$190.40M
    Revenue Growth (YoY)+6.69%
    Gross Profit$137.43M
    Operating Income$75.95M
    Pretax Income$83.36M
    Net Income$53.19M
    EBITDA$86.97M
    Reported EPS (TTM)$0.50

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 67.52% of the $424.82M in total assets.

    Cash and Equivalents$198.43M
    Total Debt$33.60M
    Net Cash$164.83M
    Net Cash Per Share$1.61
    Working Capital$199.19M
    Shareholder Equity$286.85M
    Book Value Per Share$2.80
    Tangible Book Value$226.55M
    Tangible Book Per Share$2.21
    Total Assets$424.82M
    Total Liabilities$121.35M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $2.01M of capital spending, operating cash flow left $100.20M of free cash flow.

    Operating Cash Flow$102.21M
    Capital Expenditures$2.01M
    Free Cash Flow$100.20M
    FCF Per Share$0.97
    Depreciation and Amortization$3.65M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 39.89%.

    Gross Margin72.18%
    Operating Margin39.89%
    Pretax Margin43.78%
    Net Margin27.94%
    EBITDA Margin45.68%
    FCF Margin52.63%

    Growth

    Revenue fell 0.11% a year over 3 years, and EPS grew 132.08% a year.

    Revenue Growth (3Y CAGR)-0.11%
    EPS Growth (3Y CAGR)+132.08%
    Operating Income Growth (3Y CAGR)+49.70%
    Book Value Per Share Growth (2Y CAGR)+26.64%
    Tangible Book Per Share Growth (2Y CAGR)+19.60%

    Revenue and profit by year

    Dividends and Yields

    SBC does not pay a dividend. Its free cash flow yield is 15.96%.

    Earnings Yield8.20%
    FCF Yield15.96%
    Shareholder Yield0.00%

    Peer Position

    Against 6 similar companies, SBC has the 5th highest P/E.

    P/E Ratio12.2x vs 17.2x median
    P/S Ratio3.3x vs 0.8x median
    ROIC16.95% vs 0.50% median
    Revenue Growth (Trailing 4 Quarters, YoY)+6.69% vs -5.16% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 12.20% and EPS growth at 4.98% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+12.20%
    EPS Growth Forecast (2Y CAGR)+4.98%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SBC

    What is SBC's market cap?

    SBC Medical Group Holdings has a market cap of $633.93M. Its enterprise value, which adds debt and subtracts cash, is $469.10M.

    What is SBC's P/E ratio?

    SBC Medical Group Holdings has a trailing P/E ratio of 12.2x and a forward P/E of 13.5x.

    How many shares of SBC are outstanding?

    SBC Medical Group Holdings has 102.58M shares outstanding. The count is down 0.06% from a year earlier.

    Does SBC pay a dividend?

    No. SBC Medical Group Holdings does not pay a dividend.

    How much debt does SBC have?

    SBC Medical Group Holdings has $33.60M of total debt and $198.43M of cash and equivalents, a net cash position of $164.83M.